PortfoliosLab logo

Agile Therapeutics, Inc. (AGRX)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Agile Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $9 for a total return of roughly -99.91%. All prices are adjusted for splits and dividends.

AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AGRX

Agile Therapeutics, Inc.


Agile Therapeutics, Inc. had a return of -7.49% year-to-date (YTD) and -97.87% in the last 12 months. Over the past 10 years, Agile Therapeutics, Inc. had an annualized return of -54.64%, while the S&P 500 had an annualized return of 8.56%, indicating that Agile Therapeutics, Inc. did not perform as well as the benchmark.

1 month-22.22%-5.31%
6 months-47.50%0.39%
1 year-97.87%-10.12%
5 years (annualized)-71.99%7.32%
10 years (annualized)-54.64%8.56%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Agile Therapeutics, Inc. Sharpe ratio is -0.64. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Agile Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Agile Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Agile Therapeutics, Inc. is 99.97%, recorded on Dec 20, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.97%Apr 17, 20151935Dec 20, 2022
-45.35%Jun 25, 2014122Dec 16, 201449Feb 27, 2015171
-20.5%Mar 5, 201515Mar 25, 20158Apr 7, 201523
-9.22%Jun 4, 20142Jun 5, 20144Jun 11, 20146
-3.04%Jun 20, 20141Jun 20, 20141Jun 23, 20142
-2.02%Jun 16, 20141Jun 16, 20141Jun 17, 20142
-1.52%May 30, 20141May 30, 20141Jun 2, 20142
-0.51%Apr 9, 20151Apr 9, 20151Apr 10, 20152
-0.37%Mar 2, 20151Mar 2, 20151Mar 3, 20152

Volatility Chart

Current Agile Therapeutics, Inc. volatility is 43.00%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)